30 Jun 2021
ICON advises Quantex on its sale to Dover Corporation.
PSG (a subsidiary of Dover Corporation) expands their reach into biopharma and medical applications through the acquisition of Quantex.
London-based Quantex has developed revolutionary single-use positive displacement pump technology. Its products help deliver precision and micro-dosing across a wide range of pressures, temperatures, viscosities, and flow rates. Its disposable pumps offer patients hygienic and sterile applications, maximising flexibility and delivering the highest quality patient care.
Dover Corporation is a diversified global manufacturer delivering innovative equipment and components, consumable supplies, aftermarket parts, software and digital solutions and support services. Quantex will become part of Dover’s subsidiary, PSG.
Karl Buscher PSG’s President commented, “The addition of Quantex further expands PSG’s reach into biopharma and other hygienic applications. We are excited to add Quantex’s game-changing technology to our portfolio. The Quantex recyclable portfolio of products will enable us to expand our single-use application reach across the biopharma, hygienic, food and beverage and industrial markets.”
James Kenward and Simon Moynagh at ICON Corporate Finance, the M&A advisers to Quantex commented, “We are delighted to work with founder, Dr Paul Pankhurst and his team on the sale of Quantex to the global experts in the field. This is a fantastic outcome for shareholders, employees and the game-changing technology of Quantex. Dover’s PSG provides the global scale required to fully realise the power of Quantex’s technology across multiple industries.”
Dr Paul Pankhurst, Founder and CEO of Quantex, commented on ICON Corporate Finance, “I have been very impressed by the dedication and advice of ICON, who have been critical to a successful outcome.”